This inventor holds 1 USPTO granted patent. Top assignee: Synthelabo. Active years: 1982.
Company Filing History:
Years Active: 1982
Title: Paul Fabiani: Innovator in Pharmaceutical Chemistry
Introduction
Paul Fabiani is a notable inventor based in Neuilly-sur-Seine, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work has led to advancements in the treatment of various medical conditions.
Latest Patents
Fabiani holds a patent for "2,3-Dihydro-imidazo[1,2-b]pyridazine derivatives, their preparation and addition salts with pharmaceutically acceptable acids." This patent describes compounds that are useful in therapy as antidepressants. The derivatives include various radicals, such as phenyl, halogenophenyl, and trifluoromethylphenyl, among others. His innovative approach to cyclization of specific compounds has opened new avenues for antidepressant therapies.
Career Highlights
Throughout his career, Paul Fabiani has been associated with Synthelabo, a prominent company in the pharmaceutical industry. His work has not only contributed to the company's portfolio but has also enhanced the understanding of chemical compounds used in therapeutic applications. With a focus on improving mental health treatments, his research has garnered attention in the scientific community.
Collaborations
Fabiani has collaborated with notable colleagues, including Francis Rose and Abkar Vartanian. These partnerships have facilitated the exchange of ideas and expertise, further enriching the research environment in which he operates.
Conclusion
Paul Fabiani's contributions to pharmaceutical chemistry, particularly through his patent on antidepressant derivatives, highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic options for mental health treatment.